TY - JOUR
T1 - The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease
AU - Arase, Yasuji
AU - Suzuki, Fumitaka
AU - Kobayashi, Mariko
AU - Suzuki, Yoshiyuki
AU - Kawamura, Yusuke
AU - Matsumoto, Naoki
AU - Akuta, Norio
AU - Kobayashi, Masahiro
AU - Sezaki, Hitomi
AU - Saito, Satoshi
AU - Hosaka, Tetsuya
AU - Ikeda, Kenji
AU - Kumada, Hiromitsu
AU - Ohmoto, Yuki
AU - Amakawa, Kazuhisa
AU - Tsuji, Hiroshi
AU - Hsieh, Shiun Dong
AU - Kato, Kazuhisa
AU - Tanabe, Maho
AU - Ogawa, Kyoko
AU - Hara, Shigeko
AU - Kobayashi, Tetsuro
PY - 2011
Y1 - 2011
N2 - Chronic kidney disease (CKD) is present in patients with nonalcoholic fatty liver disease (NAFLD). The aim of this retrospective study was to assess the cumulative development incidence and predictive factors for new onset of CKD in Japanese patients with NAFLD. Methods A total of 5,561 NAFLD patients without CKD were enrolled. CKD was defined as either an estimated glomerular filtration rate of <60 mL/min/1.73 m2 or dipstick proteinuria (≥ +1). A blood sample and a urine sample were taken for routine analyses during follow-up. The mean observation period was 5.5 years. The primary goal is the new development of CKD. Independent factors associated with new development of CKD were analyzed by using the Kaplan-Meyer method and the Cox proportional hazards model. Results Of 5.561 NAFLD patients, 263 patients developed CKD. The cumulative development rate of CKD was 3.1% at the 5th year and 12.2% at the 10th year. Multivariate Cox proportional hazards analysis showed that CKD development in patients with NAFLD occurred when patient had low level of GFR of 60-75 mL/ min/1.73 m2 [hazard ratio:2.75; 95% confidence interval (CI) =1.93-3.94; p<0.001], age of ≥50 years (hazard ratio: 2.67; 95% CI=2.06-3.46; p<0.001), diabetes (hazard ratio: 1.92; 95% CI=1.45-2.54; p<0.001), hypertension (hazard ratio: 1.69; 95% CI=1.25-2.29; p<0.001), and elevated serum gamma-glutamyltransferase of ≥109 IU/L(hazard ratio: 1.35; 95% CI=1.02-1.78; p=0.038). Conclusion Our retrospective study indicates that the annual incidence of CKD in Japanese patients with NAFLD is about 1.2%. Five factors of low eGFR level, aging, type 2 diabetes, hypertension, and elevated gamma-glutamyltransferase, increases the risk of the development of CKD.
AB - Chronic kidney disease (CKD) is present in patients with nonalcoholic fatty liver disease (NAFLD). The aim of this retrospective study was to assess the cumulative development incidence and predictive factors for new onset of CKD in Japanese patients with NAFLD. Methods A total of 5,561 NAFLD patients without CKD were enrolled. CKD was defined as either an estimated glomerular filtration rate of <60 mL/min/1.73 m2 or dipstick proteinuria (≥ +1). A blood sample and a urine sample were taken for routine analyses during follow-up. The mean observation period was 5.5 years. The primary goal is the new development of CKD. Independent factors associated with new development of CKD were analyzed by using the Kaplan-Meyer method and the Cox proportional hazards model. Results Of 5.561 NAFLD patients, 263 patients developed CKD. The cumulative development rate of CKD was 3.1% at the 5th year and 12.2% at the 10th year. Multivariate Cox proportional hazards analysis showed that CKD development in patients with NAFLD occurred when patient had low level of GFR of 60-75 mL/ min/1.73 m2 [hazard ratio:2.75; 95% confidence interval (CI) =1.93-3.94; p<0.001], age of ≥50 years (hazard ratio: 2.67; 95% CI=2.06-3.46; p<0.001), diabetes (hazard ratio: 1.92; 95% CI=1.45-2.54; p<0.001), hypertension (hazard ratio: 1.69; 95% CI=1.25-2.29; p<0.001), and elevated serum gamma-glutamyltransferase of ≥109 IU/L(hazard ratio: 1.35; 95% CI=1.02-1.78; p=0.038). Conclusion Our retrospective study indicates that the annual incidence of CKD in Japanese patients with NAFLD is about 1.2%. Five factors of low eGFR level, aging, type 2 diabetes, hypertension, and elevated gamma-glutamyltransferase, increases the risk of the development of CKD.
KW - Chronic kidney disease
KW - Gamma-glutamyltransferase
KW - Nonalcoholic fatty liver disease
UR - http://www.scopus.com/inward/record.url?scp=79957619541&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.50.5043
DO - 10.2169/internalmedicine.50.5043
M3 - Article
C2 - 21576832
AN - SCOPUS:79957619541
SN - 0918-2918
VL - 50
SP - 1081
EP - 1087
JO - Internal Medicine
JF - Internal Medicine
IS - 10
ER -